Fmr LLC Acumen Pharmaceuticals, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 2,029,736 shares of ABOS stock, worth $4.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,029,736

Previous 2,025,623 0.2%

Holding current value

$4.55 Million

Previous $2.23 Million 5.66%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$0.9 - $1.27 $3,701 - $5,223	4,113 Added 0.2%	2,029,736 $2.35 Million
Q1 2025 May 12, 2025	BUY	$1.1 - $1.9 $2,049 - $3,539	1,863 Added 0.09%	2,025,623 $2.23 Million
Q4 2024 Feb 13, 2025	SELL	$1.72 - $3.27 $7,494 - $14,247	-4,357 Reduced 0.21%	2,023,760 $3.48 Million
Q3 2024 Nov 13, 2024	BUY	$2.22 - $3.54 $13,351 - $21,289	6,014 Added 0.3%	2,028,117 $5.03 Million
Q2 2024 Aug 13, 2024	SELL	$2.14 - $4.01 $143,159 - $268,256	-66,897 Reduced 3.2%	2,022,103 $4.89 Million
Q1 2024 May 13, 2024	BUY	$2.97 - $4.64 $6.2 Million - $9.69 Million	2,089,000 New	2,089,000 $8.46 Million
Q3 2023 Nov 13, 2023	BUY	$4.15 - $9.72 $747 - $1,749	180 Added 37.74%	657 $2,000
Q2 2023 Aug 11, 2023	SELL	$3.59 - $6.59 $725 - $1,331	-202 Reduced 29.75%	477 $2,000
Q1 2023 May 11, 2023	SELL	$3.75 - $6.65 $825 - $1,463	-220 Reduced 24.47%	679 $2,000
Q2 2022 Aug 12, 2022	SELL	$3.08 - $4.88 $2,892 - $4,582	-939 Reduced 51.09%	899 $4,000
Q1 2022 May 13, 2022	SELL	$3.91 - $6.73 $44,816 - $77,139	-11,462 Reduced 86.18%	1,838 $7,000
Q4 2021 Feb 14, 2022	SELL	$6.54 - $15.31 $613,452 - $1.44 Million	-93,800 Reduced 87.58%	13,300 $90,000
Q3 2021 Nov 15, 2021	BUY	$14.5 - $20.28 $1.55 Million - $2.17 Million	107,100 New	107,100 $1.59 Million

Others Institutions Holding ABOS

# of Institutions

Shares Held

38.8M

Call Options Held

31.5K

Put Options Held

View Full List

About Acumen Pharmaceuticals, Inc.

Ticker ABOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,503,100
Market Cap $90.7M
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...

More about ABOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account